PRPO — Precipio, Inc.

—
Nasdaq · Unknown · Unknown · CIK 1043961 ·
Last close
$19.17
Market Cap
$34.37M
52W High
$33.63
52W Low
$17.79
ADV30
34,456
Next earnings
—
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 7,331,000 3,378,000 2,000 -8,000 21,714,000 3,576,000 6,848,000
Jun 2026 7,021,000 3,136,000 -599,000 -219,000 21,321,000 3,075,000 6,563,000
Mar 2026 6,711,000 2,725,000 -1,428,000 -1,443,000 20,803,000 2,604,000 6,636,000
Dec 2025 6,699,000 3,132,000 542,000 526,000 21,317,000 2,651,000 6,756,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,700,000
Investing CF
$-313,000
Financing CF
$-116,000
CapEx
$-313,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.98
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-104,473,000
Inventory
$911,000
Receivables
$2,047,000
ST Investments
—
EBIT TTM
$-1,094,000
Pretax Income TTM
$-1,144,000
Interest Exp TTM
$50,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$27,762,000
EBITDA
$-56,000
Free Cash Flow
$1,281,875
Enterprise Value
$39,793,652
Total Cash
$3,576,000
Total Debt
$3,692,000
Shares Out
1,792,935
Trailing EPS
$-0.59
Book Value
$8.29
ROE
-8.0%
ROA
-4.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 24,049,000 -1,202,000 -363,000 21,317,000 6,756,000 14,561,000 685,000
Dec 2024 18,532,000 -4,216,000 -4,290,000 16,996,000 4,902,000 12,094,000 439,000
Dec 2023 15,197,000 -7,620,000 -5,853,000 18,101,000 3,672,000 14,429,000 -3,559,000
Dec 2022 9,412,000 -12,797,000 -12,203,000 21,504,000 5,137,000 16,302,000 -7,721,000

TTM Snapshot

Revenues TTM
$27,198,000
NetIncome TTM
$-1,215,000
OpCashFlow TTM
—
Assets (Latest)
$21,321,000
Forward EPS
$0.39

Peers — same industry

TickerNameMarket CapLastDaily %
POAS PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd $34.37M $2.09 —
ACCL Acco Group Holdings Ltd $34.18M $2.45 —
ACFN ACORN ENERGY, INC. $34.09M $13.45 —
LOMLF Lion One Metals Ltd. $33.96M $0.08 —
EQTRF Altamira Gold Corp. $35.01M $0.12 —

News headlines (Yahoo Finance, 1h cache)

PRPO Stock Slips Post Q3 Earnings Despite Revenue and Product Growth
2026-11-16 16:00 · Yahoo
Precipio Announces Q3-2026 Financial Results
2026-11-11 18:21 · Yahoo
Precipio, Inc. Q3 2026 Earnings Call Summary
2026-11-11 13:30 · Yahoo
Precipio (PRPO) Q3 2026 Earnings Call Transcript
2026-11-11 10:28 · Yahoo
Precipio Announces Q3-2026 Shareholder Update Call
2026-10-29 17:54 · Yahoo
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
2026-08-24 16:37 · Yahoo
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record Revenue and Positive EBITDA Mark ...
2026-08-21 03:02 · Yahoo
Precipio Announces Q2-2026 Financial Results
2026-08-14 20:00 · Yahoo
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
2026-06-12 17:00 · Yahoo
Precipio, Inc. Q2 2026 Earnings Call Summary
2026-08-15 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.